Anticoagulation in acute cardiac care in patients with chronic kidney disease

Donal Reddan1, Lynda A Szczech, Susan O'Shea

  • 1Duke Institute of Renal Outcomes Research and Health Policy, Duke University Medical Center, Durham, NC 27710, USA. redda001@mc.duke.edu

Insights

Direct thrombin inhibitors offer a promising alternative to heparin for patients with chronic kidney disease (CKD) and cardiovascular disease, especially those at high bleeding risk. Dose adjustments are crucial for those with advanced renal insufficiency.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Growing prevalence of patients with coexisting chronic kidney disease (CKD) and cardiovascular disease presents treatment challenges.
  • Limited pharmacokinetic and clinical trial data exist for managing these complex patient populations.
  • Cardiovascular disease risk is significantly elevated in patients with CKD.

Purpose of the Study:

  • To review the cardiovascular disease risks associated with CKD.
  • To evaluate the use of anticoagulation for acute cardiovascular events in CKD patients.
  • To assess the role and clinical efficacy of direct thrombin inhibitors, specifically bivalirudin, in patients with renal disease and acute coronary syndromes.

Main Methods:

  • Literature review focusing on cardiovascular disease in CKD.
  • Analysis of clinical trial data and pharmacokinetic studies related to anticoagulation in renal insufficiency.
  • Evaluation of direct thrombin inhibitors (bivalirudin, argatroban) as alternatives to heparin.

Main Results:

  • Direct thrombin inhibitors show potential as alternatives to heparin in patients with renal insufficiency and increased bleeding risk.
  • Bivalirudin's clinical efficacy in acute coronary syndromes within this patient group was specifically examined.
  • Heparin use in CKD patients is associated with increased bleeding risk.

Conclusions:

  • Direct thrombin inhibitors, including bivalirudin and argatroban, are promising anticoagulation options for patients with renal insufficiency.
  • These agents may offer a safer profile compared to heparin in CKD patients at high risk of bleeding.
  • Dose modification of direct thrombin inhibitors is essential for patients with advanced renal insufficiency to manage altered drug excretion.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...